Edgewise Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Edgewise Therapeutics, Inc. (EWTX) reported Earnings Per Share, Basic and Diluted of -$0.26 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-10
- Edgewise Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.26.
- Edgewise Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.21.
- Edgewise Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$4.37.
- Edgewise Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$3.68.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month |
|---|---|---|---|
| 2021-09-30 | -$0.26 10-Q · filed 2021-11-10 | -$0.47 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$0.90 10-Q · filed 2021-11-10 |
| 2021-06-30 | -$0.21 10-Q · filed 2021-08-09 | -$0.67 10-Q · filed 2021-08-09 | |
| 2021-03-31 | -$4.37 10-Q · filed 2021-05-13 | ||
| 2020-09-30 | -$3.68 10-Q · filed 2021-11-10 | -$9.98 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$16.62 10-Q · filed 2021-11-10 |
| 2020-06-30 | -$7.43 10-Q · filed 2021-08-09 | -$14.98 10-Q · filed 2021-08-09 | |
| 2020-03-31 | -$7.57 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |